These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38722741)

  • 1. Identification of WNK1 as a therapeutic target to suppress IgH/MYC expression in multiple myeloma.
    Ye T; Mishra AK; Banday S; Li R; Hu K; Coleman MM; Shan Y; Chowdhury SR; Zhou L; Pak ML; Simone TM; Malonia SK; Zhu LJ; Kelliher MA; Green MR
    Cell Rep; 2024 May; 43(5):114211. PubMed ID: 38722741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery platform for inhibitors of IgH gene enhancer activity.
    Dolloff NG
    Cancer Biol Ther; 2019; 20(4):571-581. PubMed ID: 30481117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction to c-MYC in multiple myeloma.
    Holien T; Våtsveen TK; Hella H; Waage A; Sundan A
    Blood; 2012 Sep; 120(12):2450-3. PubMed ID: 22806891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of WNK1 in MYC-dependent early mouse thymocyte development.
    Köchl R; Vanes L; Llorian Sopena M; Chakravarty P; Hartweger H; Fountain K; White A; Cowan J; Anderson G; Tybulewicz VL
    Elife; 2020 Oct; 9():. PubMed ID: 33051000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells
    Zhang Y; Zhou L; Bandyopadhyay D; Sharma K; Allen AJ; Kmieciak M; Grant S
    Clin Cancer Res; 2019 Oct; 25(20):6195-6205. PubMed ID: 31358538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNK1 Enhances Migration and Invasion in Breast Cancer Models.
    Jaykumar AB; Jung JU; Parida PK; Dang TT; Wichaidit C; Kannangara AR; Earnest S; Goldsmith EJ; Pearson GW; Malladi S; Cobb MH
    Mol Cancer Ther; 2021 Oct; 20(10):1800-1808. PubMed ID: 34253593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
    Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
    Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.
    Lind J; Aksoy O; Prchal-Murphy M; Fan F; Fulciniti M; Stoiber D; Bakiri L; Wagner EF; Zwickl-Traxler E; Sattler M; Kollmann K; Vallet S; Podar K
    Blood Cancer J; 2024 Aug; 14(1):138. PubMed ID: 39160158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.
    Saha MN; Abdi J; Yang Y; Chang H
    Oncotarget; 2016 Feb; 7(6):7149-60. PubMed ID: 26771839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
    Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
    Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
    Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y
    Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC addiction: a potential therapeutic target in MM.
    Kuehl WM; Bergsagel PL
    Blood; 2012 Sep; 120(12):2351-2. PubMed ID: 22996653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications.
    Harada T; Ohguchi H; Grondin Y; Kikuchi S; Sagawa M; Tai YT; Mazitschek R; Hideshima T; Anderson KC
    Leukemia; 2017 Dec; 31(12):2670-2677. PubMed ID: 28490812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
    Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
    BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
    Ma Y; Zong H; Pan P; Shang H; Yang X
    Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
    Gauduchon J; Gouilleux F; Maillard S; Marsaud V; Renoir JM; Sola B
    Clin Cancer Res; 2005 Mar; 11(6):2345-54. PubMed ID: 15788686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma.
    Yao R; Xie Y; Sun X; Zhang M; Zhou J; Liu L; Gao J; Xu K
    Drug Des Devel Ther; 2020; 14():3983-3993. PubMed ID: 33061303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.
    Ronca R; Ghedini GC; Maccarinelli F; Sacco A; Locatelli SL; Foglio E; Taranto S; Grillo E; Matarazzo S; Castelli R; Paganini G; Desantis V; Cattane N; Cattaneo A; Mor M; Carlo-Stella C; Belotti A; Roccaro AM; Presta M; Giacomini A
    Cancer Res; 2020 Jun; 80(11):2340-2354. PubMed ID: 32094301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.